SDF-1α stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 14, 2009, Pages 5675-5680

  Pi, Xinchun ^a   Wu, Yaxu ^a   Ferguson III, James E ^a   Portbury, Andrea L ^a   Patterson, Cam ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 7; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; DUAL SPECIFICITY PHOSPHATASE; DUSP16 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CATTLE; CELL CULTURE; CELL MOTION; CYTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; DUAL-SPECIFICITY PHOSPHATASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION;

EID: 65249150214     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0809568106     Document Type: Article

References (41)

1. Horuk R (2001) Chemokine receptors. Cytokine Growth Factor Rev 12:313-335.
2. Dias S, Choy M, Rafii S (2001) The role of CXC chemokines in the regulation of tumor angiogenesis. Cancer Invest 19:732-738.
3. Pourtau J, et al. (1999) Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M. FEBS Lett 459:453-457.
4. Molino M, et al. (2000) CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochim Biophys Acta 1500:227-240.
5. MirshahiF,et al. (2000) SDF-1 activity onmicrovascular endothelial cells: Consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99:587-594.
6. Askari AT, et al. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703.
7. Yamaguchi J, et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328.
8. Ceradini DJ, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10:858-864.
9. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599.
10. Ma Q, et al. (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95:9448-9453.
11. BagriA, et al. (2002) The chemokine SDF1 regulates migrationof dentate granule cells. Development 129:4249-4260.
12. Lu M, Grove EA, Miller RJ (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99:7090-7095.
13. Nagasawa T, et al. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638.
14. Tachibana K, et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-594.
15. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines J Biol Chem 273:4282-4287.
16. Salcedo R, et al. (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154:1125-1135.
17. Zheng H, Fu G, Dai T, Huang H (2007) Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50:274-280.
18. Resnick L, Fennell M (2004) Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov Today 9:932-939.
19. Pi X, et al. (2007) Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J Cell Biol 179:1569-1582.
20. Hatano N, et al. (2003) Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8:847-856.
21. Mudgett JS, et al. (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459.
22. Hu X, et al. (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116:654-663.
23. Ziche M, Morbidelli L (2000) Nitric oxide and angiogenesis. J Neurooncol 50:139-148.
24. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117:4619-4628.
25. Willoughby EA, Collins MK (2005) Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2. J Biol Chem 280:25651-25658.
26. Kamata H, et al. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-661.
27. Cherla RP, Ganju RK (2001) Stromal cell-derived factor 1 alpha-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J Immunol 166:3067-3074.
28. Sun Y, Cheng Z, Ma L, Pei G (2002) Beta-arrestin2 is critically involved in CXCR4- mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277:49212-49219.
29. Kaminski A, et al. (2008) Endothelial NOS is required for SDF-WCXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells. Lab Invest 88:58-69.
30. Hiasa K, et al. (2004) Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway. Circulation 109:2454-2461.
31. Stamler JS (1994) Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78:931-936.
32. Hess DT, etal. (2005) Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6:150-166.
33. Park HS, Huh SH, Kim MS, Lee SH, Choi EJ (2000) Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. ProcNatl Acad Sci USA 97:14382-14387.
34. Mishra OP, Zubrow AB, Ashraf QM (2004) Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neuroscience 123:179-186.
35. Pei DS,etal. (2008) Exogenous nitric oxide negatively regulates c-Jun N-terminal kinase activation via inhibiting endogenous NO-induced S-nitrosylation during cerebral ischemia and reperfusion in rat hippocampus. JNeurochem 106:1952-1963.
36. Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231-1236.
37. Urbich C, DimmelerS (2004) Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 95:343-353.
38. Moore MA, et al. (2001) Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci 938:36-45; discussion 45-37.
39. Forrester MT, Foster MW, Stamler JS (2007) Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem 282:13977-13983.
40. Pi X, et al. (2005) BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circ Res 96:1145-1151.
41. Ren R, et al. (2006) Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses. Blood 109:2847-2853.